Trends and Perspectives for Improving Quality of Chronic Kidney Disease Care: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

[1]  N. Roetker,et al.  US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  E. Schaeffner,et al.  Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex. , 2023, The New England journal of medicine.

[3]  Y. Rochev,et al.  IBD disease-modifying therapies: insights from emerging therapeutics. , 2023, Trends in molecular medicine.

[4]  D. M. van der Heijde,et al.  Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis , 2022, Annals of the Rheumatic Diseases.

[5]  J. Lieske,et al.  Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. , 2022, Kidney international.

[6]  C. Jacquelinet,et al.  Five-Year Symptom Trajectories in Nondialysis-Dependent CKD Patients , 2022, Clinical journal of the American Society of Nephrology : CJASN.

[7]  C. Wanner,et al.  What should European nephrology do with the new CKD-EPI equation? , 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  F. Van de Werf,et al.  Polypill Strategy in Secondary Cardiovascular Prevention. , 2022, The New England journal of medicine.

[9]  C. Kocks,et al.  Urinary single-cell sequencing captures kidney injury and repair processes in human acute kidney injury. , 2022, Kidney international.

[10]  J. Carrero,et al.  Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility , 2022, Kidney international reports.

[11]  Chuanhua Yu,et al.  Burden of diabetes and kidney disease attributable to non-optimal temperature from 1990 to 2019: A systematic analysis from the Global Burden of Disease Study 2019. , 2022, The Science of the total environment.

[12]  Daniel Ranch,et al.  Health Care Transition in Adolescents and Young Adults With Chronic Kidney Disease: Focus on the Individual and Family Support Systems. , 2022, Advances in chronic kidney disease.

[13]  A. Köttgen,et al.  Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2022, Kidney international.

[14]  Muirne C. S. Paap,et al.  Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis , 2022, PLoS medicine.

[15]  Jean A. Tkach,et al.  Multiparametric quantitative renal MRI in children and young adults: comparison between healthy individuals and patients with chronic kidney disease , 2022, Abdominal Radiology.

[16]  Connie M. Rhee,et al.  Patient-centred approaches for the management of unpleasant symptoms in kidney disease , 2022, Nature Reviews Nephrology.

[17]  E. McDonald,et al.  Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial , 2022, Canadian journal of kidney health and disease.

[18]  Shuhei Watanabe,et al.  Association of Polypharmacy with Kidney Disease Progression in Adults with CKD , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[19]  W. Dou,et al.  Native T1 Mapping in Assessing Kidney Fibrosis for Patients With Chronic Glomerulonephritis , 2021, Frontiers in Medicine.

[20]  G. Bonsel,et al.  A multi-level approach for the use of routinely collected patient-reported outcome measures (PROMs) data in healthcare systems , 2021, Journal of Patient-Reported Outcomes.

[21]  B. Rovin,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[22]  N. Powe,et al.  New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. , 2021, The New England journal of medicine.

[23]  F. Dekker,et al.  Person centred care provision and care planning in chronic kidney disease: which outcomes matter? A systematic review and thematic synthesis of qualitative studies , 2021, BMC Nephrology.

[24]  I. D. de Boer,et al.  Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy , 2021, Trials.

[25]  N. Powe,et al.  A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  M. Woodward,et al.  Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium , 2021, Hypertension.

[27]  Christopher J. L. Murray,et al.  Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study , 2021, The Lancet.

[28]  D. Kleinbaum,et al.  Polypharmacy and mortality association by chronic kidney disease status: The REasons for Geographic And Racial Differences in Stroke Study , 2021, Pharmacology research & perspectives.

[29]  S. Letovsky,et al.  Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database , 2021, Diabetes Care.

[30]  J. Coresh,et al.  Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations , 2021, Diabetes Care.

[31]  K. Jager,et al.  Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls , 2021, Clinical Kidney Journal.

[32]  M. Gebregziabher,et al.  Significant hospitalization cost savings to the payer with a pharmacist‐led mobile health intervention to improve medication safety in kidney transplant recipients , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  Jennifer E. Flythe,et al.  Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis , 2021, BMC Nephrology.

[34]  Robert J. Ziemba,et al.  Excess Death Estimates in Patients with End-Stage Renal Disease — United States, February–August 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[35]  M. Shlipak,et al.  The Promise of Tubule Biomarkers in Kidney Disease: A Review. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  Rasheeda K. Hall,et al.  Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  J. Braithwaite,et al.  Patient‐reported outcome measures (PROMs): A review of generic and condition‐specific measures and a discussion of trends and issues , 2021, Health expectations : an international journal of public participation in health care and health policy.

[38]  M. Gebregziabher,et al.  Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[39]  T. A. Wihastuti,et al.  Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review , 2021, Journal of public health research.

[40]  Hajeong Lee,et al.  Pharmacist-Led Collaborative Medication Management for the Elderly with Chronic Kidney Disease and Polypharmacy , 2021, International journal of environmental research and public health.

[41]  Michael T. Eadon,et al.  Rationale and design of the Kidney Precision Medicine Project. , 2021, Kidney international.

[42]  W. Cushman,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. , 2021, Kidney international.

[43]  Xiaoshuang Liu,et al.  Evaluation of Renal Fibrosis by Mapping Histology and Magnetic Resonance Imaging , 2021, Kidney Diseases.

[44]  Erica F. Crannage,et al.  Assessing the Impact of Comprehensive Medication Management on Achievement of the Quadruple Aim. , 2021, The American journal of medicine.

[45]  A. Cheung,et al.  Clinical events and patient-reported outcome measures during CKD progression: findings from the CRIC study. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  M. Nassar,et al.  Diffusion Tensor Imaging in early prediction of renal fibrosis in patients with renal disease: Functional and histopathological correlations , 2020, International journal of clinical practice.

[47]  G. Riemekasten,et al.  Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods , 2020, Scientific Reports.

[48]  Y. Lai,et al.  Effectiveness of Multidisciplinary Care for Chronic Kidney Disease: A Systematic Review. , 2020, Worldviews on evidence-based nursing.

[49]  A. Teixeira-Pinto,et al.  Patient needs and priorities for patient navigator programmes in chronic kidney disease: a workshop report , 2020, BMJ Open.

[50]  Jenny I. Shen,et al.  The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2020, Kidney international.

[51]  Mahboob Rahman,et al.  Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  T. Wilt,et al.  Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis , 2020, Journal of General Internal Medicine.

[53]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[54]  C. Jacquelinet,et al.  Adverse Drug Reactions in Patients with CKD. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[55]  L. Karliner,et al.  Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  David S Jones,et al.  Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms. , 2020, The New England journal of medicine.

[57]  P. Durek,et al.  Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis , 2020, Frontiers in Immunology.

[58]  D. Weiner,et al.  Multidisciplinary Medication Therapy Management and Hospital Readmission in Patients Undergoing Maintenance Dialysis: A Retrospective Cohort Study. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[60]  M. Gilchrist,et al.  Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol , 2020, BMC Nephrology.

[61]  F. Dekker,et al.  Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[62]  A. Rule,et al.  Should the definition of CKD be changed to include age-adapted GFR criteria? YES. , 2020, Kidney international.

[63]  J. Coresh,et al.  "Should the definition of CKD be changed to include age-adapted GFR criteria?": Con: the evaluation and management of CKD, not the definition, should be age-adapted. , 2020, Kidney international.

[64]  D. Bell,et al.  Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children , 2019, JAMA network open.

[65]  D. O’Mahony.  STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress , 2019, Expert review of clinical pharmacology.

[66]  Anushka Patel,et al.  Association of Multifaceted Mobile Technology-Enabled Primary Care Intervention With Cardiovascular Disease Risk Management in Rural Indonesia. , 2019, JAMA cardiology.

[67]  J. Coresh,et al.  Strengths and limitations of estimated and measured GFR , 2019, Nature Reviews Nephrology.

[68]  J. Coresh,et al.  Measured and estimated glomerular filtration rate: current status and future directions , 2019, Nature Reviews Nephrology.

[69]  B. Hemmelgarn,et al.  Patient-Reported Outcome Measures in CKD Care: The Importance of Demonstrating Need and Value. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[70]  A. Slade,et al.  Patient and Clinician Perspectives on Electronic Patient-Reported Outcome Measures in the Management of Advanced CKD: A Qualitative Study. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[71]  K. Khunti,et al.  Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease. , 2019, Kidney international.

[72]  Wei Yang,et al.  Reconsidering the Consequences of Using Race to Estimate Kidney Function. , 2019, JAMA.

[73]  S. Francis,et al.  Quantitative assessment of renal structural and functional changes in chronic kidney disease using multi-parametric magnetic resonance imaging , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[74]  Julio Saez-Rodriguez,et al.  Big science and big data in nephrology. , 2019, Kidney international.

[75]  A. Köttgen,et al.  Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study , 2019, Clinical kidney journal.

[76]  A. Levey,et al.  Improving glomerular filtration rate estimation. , 2019, Kidney international.

[77]  D. Rifkin,et al.  Patients,' Nephrologists,' and Predicted Estimations of ESKD Risk Compared with 2-Year Incidence of ESKD. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[78]  J. Hanlon,et al.  American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults , 2019, Journal of the American Geriatrics Society.

[79]  V. Jha,et al.  Establishing a Core Outcome Measure for Life Participation: a Standardized Outcomes in Nephrology - Kidney Transplantation (SONG-Tx) Consensus Workshop Report. , 2019, Transplantation.

[80]  Chelsea E. Hawley,et al.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease , 2018, Drugs & Aging.

[81]  Elizabeth W. Staton,et al.  Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care , 2018, JAMA network open.

[82]  G. Mancia,et al.  Ten Commandments of the 2018 ESC/ESH HTN Guidelines on Hypertension in Adults. , 2018, European heart journal.

[83]  A. Mokdad,et al.  Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. , 2018, Kidney international.

[84]  J. Fink,et al.  Medication Safety Principles and Practice in CKD. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[85]  J. Coresh,et al.  Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults , 2018, Drugs & Aging.

[86]  Marcello Tonelli,et al.  The global burden of kidney disease and the sustainable development goals , 2018, Bulletin of the World Health Organization.

[87]  J. Coresh,et al.  Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference , 2018, Kidney international.

[88]  M. Stuber,et al.  Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease. , 2018, Kidney international.

[89]  R. Elashoff,et al.  A Cluster‐Randomized Trial of Blood‐Pressure Reduction in Black Barbershops , 2018, The New England journal of medicine.

[90]  David W. Johnson,et al.  Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. , 2018, Kidney international supplements.

[91]  Smeeta Sinha,et al.  Understanding the implementation of ‘sick day guidance’ to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation , 2017, BMJ Open.

[92]  C. Bell,et al.  Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[93]  Gillian E. Caughey,et al.  What is polypharmacy? A systematic review of definitions , 2017, BMC Geriatrics.

[94]  S. Francis,et al.  Multiparametric Renal Magnetic Resonance Imaging: Validation, Interventions, and Alterations in Chronic Kidney Disease , 2017, Front. Physiol..

[95]  Jing He,et al.  The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis , 2017, International Urology and Nephrology.

[96]  Deborah A. Greenwood,et al.  A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support , 2017, Journal of diabetes science and technology.

[97]  A. Kengne,et al.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening , 2017, BMJ Global Health.

[98]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[99]  Ashutosh Kumar Singh,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[100]  L. Strotman,et al.  The Future of Precision Medicine in Oncology. , 2016, Clinics in laboratory medicine.

[101]  D. Webb,et al.  Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. , 2016, Kidney international.

[102]  J. Coresh,et al.  Race, APOL1 Risk, and eGFR Decline in the General Population. , 2016, Journal of the American Society of Nephrology : JASN.

[103]  F. Kronenberg,et al.  Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. , 2016, JAMA.

[104]  K. Shedden,et al.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker , 2015, Science Translational Medicine.

[105]  Raymond Vanholder,et al.  International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology , 2015, The Lancet.

[106]  A. Garg,et al.  Worldwide access to treatment for end-stage kidney disease: a systematic review , 2015, The Lancet.

[107]  M. Tonelli,et al.  Cause of Death in Patients with Reduced Kidney Function. , 2015, Journal of the American Society of Nephrology : JASN.

[108]  G. Burmester,et al.  Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response , 2013, Annals of the rheumatic diseases.

[109]  P. Houillier,et al.  Performance of GFR estimating equations in African Europeans: basis for a lower race-ethnicity factor than in African Americans. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[110]  Chrysta Lienczewski,et al.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multi-disciplinary approach , 2012, Kidney international.

[111]  David Moher,et al.  Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis , 2012, The Lancet.

[112]  Mark Woodward,et al.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. , 2011, Kidney international.

[113]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[114]  S. Yusuf,et al.  Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. , 2011, Kidney international.

[115]  Laura E. Clark,et al.  Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. , 2011, Kidney international.

[116]  M. Shlipak,et al.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. , 2011, JAMA.

[117]  N. Tangri,et al.  A predictive model for progression of chronic kidney disease to kidney failure. , 2011, JAMA.

[118]  Sven Schmiedl,et al.  Potentially inappropriate medications in the elderly: the PRISCUS list. , 2010, Deutsches Arzteblatt international.

[119]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[120]  N. Khan,et al.  Reduced Drug Use and Hospitalization Rates in Patients Undergoing Hemodialysis Who Received Pharmaceutical Care: A 2‐Year, Randomized, Controlled Study , 2009, Pharmacotherapy.

[121]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[122]  P. Davidson,et al.  Evolution of practice nursing in Australia. , 2006, Journal of advanced nursing.

[123]  C. Gullion,et al.  Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.

[124]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[125]  D. Bates,et al.  Guided medication dosing for inpatients with renal insufficiency. , 2001, JAMA.

[126]  J. Lewis,et al.  Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.